Cellgen is developing a bio-fluid based molecular diagnostic that will serve as a therapeutic guidance platform for cancer patients. The platform incorporates machine learning to deliver intelligent, quantitative and actionable results to oncologists in under 5 hours. Designed to detect all DNA and RNAs, Cellgen’s platform features a proprietary on-chip enrichment and detection workflow perfectly suited to be installed as the premier Companion Diagnostic testing system within leading oncology clinics. Running on Cellgen’s proprietary platform, each disposable assay will yield inclusion / exclusion data, while also leveraging proprietary machine learning algorithms to intelligently monitor and predict therapeutic response. This information will help inform patients, physicians, and others on how best to simplify and optimize life-saving clinical protocols.
Company’s Keywords:
<2
<6655000
<2012
Your request has been submitted successfully.
Own or work here?